Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Genetic Neurodegenerative Diseases, and Neuroinflammation and Neurodegeneration Mechanisms.
Novel blood‐based proteomic signatures across multiple neurodegenerative diseases
Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE study
Active elite rugby participation is associated with altered precentral cortical thickness
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
Amyloid processing in <scp>COVID</scp>‐19‐associated neurological syndromes
Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study
Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Plasma amyloid-β ratios in autosomal dominant Alzheimer’s disease: the influence of genotype
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder
A population‐based study of head injury, cognitive function and pathological markers
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
Fluid biomarkers in frontotemporal dementia: past, present and future
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
<i>PDXK</i> mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers